What We're Reading: Page 220
Industry reads hand-picked by our editors
Oct 04, 2019
-
1843
Will there ever be a cure for chronic pain?
-
The Nevada Independent
Two dozen companies could be fined $20 million by state for noncompliance with diabetes drug transparency law
-
STAT
Congress just quietly passed a bill that will cost drug makers $3 billion
-
The New York Times
Why Lifesaving Drugs May Be Missing on Your Next Flight
Oct 03, 2019
Oct 02, 2019
-
BioCentury
Trump to nominate Hahn as FDA commissioner
-
Financial Times
Insulin maker Novo Nordisk walks moral tightrope
-
Los Angeles Times
FDA tried to ban vape flavors before crisis. Obama nixed the plan.
-
Vantage
Clovis is running out of waves to catch
Oct 01, 2019
-
The Wall Street Journal
Novel Plan Aims to Settle Opioid Suits
-
Reuters
Bayer to spend over 25 billion euros in crop science R&D over 10 years
-
FiercePharma
Big Pharma CEOs' Chinese names: Here's how they look and what they mean
Sep 30, 2019
-
Bloomberg
Future of Genetically Modified Babies May Lie in Putin's Hands
-
The Washington Post
‘Out here, it’s just me’: In the medical desert of rural America, one doctor for 11,000 square miles
-
Reuters
French drugmaker Sanofi to cut around 200 jobs in Japan - source
-
STAT
Error undermines controversial study related to CRISPR babies experiment
Sep 27, 2019
Sep 26, 2019
-
The Wall Street Journal
Health-Care Investor to Build Biotech Labs in Nomad
-
The Washington Post
Shuping Wang, whistleblower who exposed China's HIV/AIDS crisis, dies at 59
-
The Independent
Labour would found state drug company to make medicines cheaper
-
Bloomberg
Takeda Is Close to Selling Emerging Market, European Drugs
Previous
